Multicenter study of Campath-1H in patients with chronic lymphocytic leukemia (B-CLL) refractory to fludarabine.

被引：0
|
作者：
Keating, MJ
Byrd, J
Rai, K
Flinn, I
Jain, V
Binet, JL
Bolin, R
Hillmen, P
Hutchinson, M
机构：
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3118
引用
收藏
页码：705A / 705A
页数：1
相关论文
共 50 条
  • [1] Campath-1H and fludarabine in combination are highly active in refractory chronic lymphocytic leukemia
    Kennedy, B
    Rawstron, A
    Carter, C
    Ryan, M
    Speed, K
    Lucas, G
    Hillmen, P
    BLOOD, 2002, 99 (06) : 2245 - 2247
  • [2] Rituximab and Campath-1H combination therapy in patients with relapsed and/or refractory chronic lymphocytic leukemia (CLL).
    Nabhan, C
    Patton, D
    Gordon, LI
    Riley, MB
    Kuzel, T
    Tallman, MS
    Rosen, ST
    BLOOD, 2003, 102 (11) : 361B - 361B
  • [3] CAMPATH-1H therapy of patients with previously untreated chronic lymphocytic leukemia (CLL).
    Lundin, J
    Björkholm, M
    Celsing, F
    Hale, G
    Hjalmar, V
    Kimby, E
    Tullgren, O
    Waldman, H
    Mellstedt, H
    Österborg, A
    ANNALS OF ONCOLOGY, 2000, 11 : 96 - 96
  • [4] CAMPATH-1H therapy of patients with previously untreated chronic lymphocytic leukemia (CLL).
    Mellstedt, H
    Österborg, A
    Lundin, J
    Björkholm, M
    Celsing, F
    Hagberg, H
    Hast, R
    Hjalmar, V
    Kimby, E
    Luthman, M
    Tullgren, O
    Werner, B
    BLOOD, 1998, 92 (10) : 490A - 490A
  • [5] Filgrastim and alemtuzumab (Campath-1H) for refractory chronic lymphocytic leukemia
    Lin, TS
    Flinn, IW
    Lucas, MS
    Porcu, P
    Sickler, J
    Moran, ME
    Lucas, DM
    Heerema, NA
    Grever, MR
    Byrd, JC
    LEUKEMIA, 2005, 19 (07) : 1207 - 1210
  • [6] Filgrastim and alemtuzumab (Campath-1H) for refractory chronic lymphocytic leukemia
    T S Lin
    I W Flinn
    M S Lucas
    P Porcu
    J Sickler
    M E Moran
    D M Lucas
    N A Heerema
    M R Grever
    J C Byrd
    Leukemia, 2005, 19 : 1207 - 1210
  • [7] Campath-1H for chronic lymphocytic leukemia
    Rai, KR
    CLINICAL LYMPHOMA, 2002, 3 (02): : 73 - 74
  • [8] UCN-01 chemosensitizes human B-chronic lymphocytic leukemia (B-CLL) cells to the effects of fludarabine.
    Willis, C
    Byrd, JC
    Shinn, C
    Flinn, IW
    Grever, MR
    BLOOD, 1999, 94 (10) : 127A - 127A
  • [9] COMPLETE AND PARTIAL-RESPONSE (CR, PR) IN TREATMENT OF ADVANCED REFRACTORY B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) USING CAMPATH-1H
    JANSON, D
    NISSELHOROWITZ, S
    SATTLER, M
    RAI, KR
    BLOOD, 1993, 82 (10) : A139 - A139
  • [10] Phase I study of rituximab and CAMPATH-1H in patients with relapsed or refractory chronic lymphocytic leukemia.
    Nabhan, C
    Tallman, MS
    Riley, MB
    Fitzpatrick, J
    Gordon, LI
    Gartenhaus, R
    Kuzel, T
    Siegel, R
    Rosen, ST
    BLOOD, 2001, 98 (11) : 365A - 365A
12345